Cromos Pharma, where the patients are

QRxPharma

Aesica, QRxPharma collaborate to promote Stealth Beadlets

Wednesday, July 24, 2013 09:30 AM

Aesica Pharmaceuticals, a global contract development and manufacturing organization (CDMO), has partnered with pharmaceutical company QRxPharma to globally promote QRxPharma’s proprietary Stealth Beadlets abuse deterrence technology.

More... »

CRF Health eCOA webinar series

SynteractHCR hires Bill Pierce and Richard Paul

Thursday, April 4, 2013 08:00 AM

SynteractHCR, a full-service CRO, has hired two new senior executives to support the company's growth on a global scale following its recent merger. SynteractHCR has appointed Bill Pierce as chief information officer and Richard Paul as chief medical officer and vice president medical/regulatory affairs.

More... »


QRxPharma inks strategic collaboration with Paladin Labs

Wednesday, October 10, 2012 11:31 AM

QRxPharma, a commercial-stage specialty pharmaceutical company based in Bedminster, N.J., signed a licensing agreement with Paladin Labs, specialty pharmaceutical company based in Montreal, for the Canadian commercialization rights to Moxduo, a patented, immediate-release formulation of morphine and oxycodone. 

More... »

QRxPharma concludes phase I studies for MoxDuo CR

Wednesday, April 11, 2012 03:28 PM

Australia-based QRxPharma has completed two phase I studies in healthy volunteers for MoxDuo CR, a controlled-release Dual-Opioid utilizing a 3:2 ratio of morphine and oxycodone.

More... »

Actavis partners with QRxPharma to launch novel pain medication in U.S.

Thursday, December 22, 2011 09:46 AM
Actavis has entered into a binding letter of intent (LOI) with QRxPharma to commercialize MoxDuo IR in the United States.

More... »

QRxPharma files NDA for MoxDuoR IR

Wednesday, July 20, 2011 11:16 AM

QRxPharma reported the initiation of the New Drug Application (NDA) approval process for MoxDuo IR with the FDA.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs